US Stock Market Today (Dec. 17, 2025): Dow, S&P 500 and Nasdaq Futures Tick Higher Ahead of Inflation Data and Fed Speakers

US Stock Market Today (Dec. 17, 2025): Dow, S&P 500 and Nasdaq Futures Tick Higher Ahead of Inflation Data and Fed Speakers

NEW YORK — 6:15 a.m. ET, Wednesday, Dec. 17, 2025. U.S. stock futures are edging higher early Wednesday after a mixed Tuesday session, as investors recalibrate expectations for Federal Reserve rate cuts and brace for a late-week burst of inflation data. The pre-market tone is being shaped by three forces: a “noisy” jobs report that revived easing bets, a rebound in oil after fresh Venezuela headlines, and a busy stretch for earnings and deal-driven single-stock moves. markets.businessinsider.com+2Reuters+2 US stock futures rise modestly ahead of the opening bell As of roughly 5:50 a.m. ET, futures pointed to a slightly stronger start for Wall Street:
Rio Tinto (RIO) news today: Rhodes Ridge greenlights $191m study, green iron momentum builds, and Rusal court ruling adds legal noise (17 Dec 2025)

Rio Tinto (RIO) news today: Rhodes Ridge greenlights $191m study, green iron momentum builds, and Rusal court ruling adds legal noise (17 Dec 2025)

Rio Tinto plc (NYSE: RIO) is in focus on 17 December 2025 as a cluster of iron-ore growth and decarbonisation headlines land alongside a renewed legal overhang tied to its alumina joint venture with Russia’s Rusal. In Australia, Rio-backed initiatives spanning Pilbara supply growth (Rhodes Ridge) and lower‑emissions iron and steel pathways (Calix “Zesty” and the NeoSmelt consortium) are shaping the narrative, while competitive pressure around Guinea’s next wave of high-grade iron ore projects continues to build. What’s driving the Rio Tinto story on 17 December 2025 Here are the key Rio-linked developments circulating today: Rio Tinto share price check
APA Corporation Stock (APA) News Today, Forecasts, and Analyst Outlook — What’s Driving APA Shares on Dec. 17, 2025

APA Corporation Stock (APA) News Today, Forecasts, and Analyst Outlook — What’s Driving APA Shares on Dec. 17, 2025

APA Corporation (NASDAQ: APA) is back in the spotlight on Wednesday, December 17, 2025, after a sharp energy-sector slide pushed the stock notably lower in the prior session—just as crude oil whipsawed on a mix of oversupply fears and fresh geopolitical headlines. APA’s share move is happening at the intersection of three storylines investors care about right now: Below is what’s new, what analysts are forecasting, and what matters next for APA stock as of 17.12.2025. APA stock price action: why APA shares fell, and what’s happening premarket on Dec. 17 APA closed Tuesday, Dec. 16, 2025 at $23.96, down
Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune (ALT) Stock News Today (Dec. 17, 2025): Pemvidutide Catalysts, CEO Transition, and Wall Street Price Targets

Altimmune, Inc. (NASDAQ: ALT) is back in the biotech spotlight on December 17, 2025—less because the company suddenly became “safe,” and more because it’s heading into the kind of binary stretch that turns small-cap biotech charts into roller coasters: a high-stakes clinical update is expected before year-end, leadership is changing hands, and Wall Street price targets remain dramatically spread out. Shares were indicated around $5.03 early Wednesday, after closing at roughly the same level on Tuesday (Dec. 16). MarketBeat Altimmune stock price action: why traders keep circling ALT ALT has been showing the classic behavior of a catalyst-driven biotech: sharp
Compass Group PLC (CPG) in Focus Today: BNP Exane Downgrade, Share Price Moves, and What Investors Are Watching (17 December 2025)

Compass Group PLC (CPG) in Focus Today: BNP Exane Downgrade, Share Price Moves, and What Investors Are Watching (17 December 2025)

Compass Group PLC (LSE: CPG) drew fresh attention on 17 Dec 2025 after a BNP Exane downgrade. Here’s what happened today, how the stock traded, and what’s next. Compass Group PLC (LSE: CPG) — the FTSE 100 catering and support services giant — is back in the spotlight on Wednesday, 17 December 2025, after a notable analyst downgrade sparked debate about one of the company’s most important operational metrics: client retention, particularly in the US healthcare vertical. investments.halifax.co.uk Even without a new regulatory announcement from the company today, the stock is giving investors plenty to digest: a sharp difference of
GSK plc (GSK) news: FDA approves twice‑yearly asthma biologic Exdensur on Dec. 17, 2025

GSK plc (GSK) news: FDA approves twice‑yearly asthma biologic Exdensur on Dec. 17, 2025

GSK plc (GSK) announced today that the FDA approved Exdensur (depemokimab‑ulaa) for severe eosinophilic asthma in patients 12+. Here’s what it means for GSK’s respiratory pipeline, competition, and shareholders on 17.12.2025. GSK plc (LSE/NYSE: GSK) is in the spotlight on Wednesday, 17 December 2025, after the company confirmed US FDA approval for Exdensur (depemokimab‑ulaa)—a new twice‑yearly biologic for severe asthma—while also releasing its latest share buyback update through a regulatory filing. Investegate+1 Below is a full, reader-friendly rundown of all current GSK news items dated 17.12.2025, plus what they signal for patients, clinicians, and investors. Today’s GSK headlines (17.12.2025) 1)
British American Tobacco (BATS) Today: Share Buyback Updates, Board Disclosure and What Investors Are Watching (17 December 2025)

British American Tobacco (BATS) Today: Share Buyback Updates, Board Disclosure and What Investors Are Watching (17 December 2025)

British American Tobacco p.l.c. (LSE: BATS) published new buyback disclosures and a board-related update on 17 December 2025. Here’s what changed, why it matters, and what to watch next. British American Tobacco p.l.c. (BAT) closed Wednesday with its shares little changed, as investors digested a fresh set of routine—but still important—regulatory filings tied to the group’s ongoing capital returns and governance disclosures. At the close in London, British American Tobacco (BATS) was quoted around 4,284p, up 6p (+0.14%), with a market capitalisation shown at roughly £93.10bn. Hargreaves Lansdown Below is a clear rundown of everything we can identify as “current
Netflix Stock (NFLX) News Today, Dec. 17, 2025: Warner Bros. Deal Drama, Analyst Forecasts, and What Investors Are Watching

Netflix Stock (NFLX) News Today, Dec. 17, 2025: Warner Bros. Deal Drama, Analyst Forecasts, and What Investors Are Watching

Netflix, Inc. (NASDAQ: NFLX) is back in the market’s spotlight on Wednesday, December 17, 2025, as investors weigh two competing narratives: a streaming leader with improving cash generation—versus a blockbuster M&A move that could reshape Hollywood (and invite regulatory headaches). In early U.S. premarket trading, NFLX was hovering around $94.6. StockAnalysis What’s driving attention today isn’t a new season drop or a subscriber headline. It’s the escalating bidding war around Warner Bros. Discovery’s assets and what that could mean for Netflix’s balance sheet, strategy, and valuation. Reuters+1 Netflix stock price today: where NFLX stands on Dec. 17, 2025 Netflix shares
Standard Chartered STAN hits fresh 52-week high as share buyback continues and investors track Germany regulator order

Standard Chartered STAN hits fresh 52-week high as share buyback continues and investors track Germany regulator order

LONDON — 17 December 2025 — Standard Chartered PLC (ticker STAN) is back in the spotlight today after the bank disclosed another round of share repurchases under its ongoing buyback programme and the stock pushed to a new 52-week high during Wednesday trading. Investegate+1 At the same time, investors are still digesting a German regulatory order announced this week that requires the lender’s local unit to address organisational shortcomings and hold additional capital—an update that adds a note of caution even as the share price rallies. Reuters Today’s Standard Chartered headlines in one minute Share buyback update: what Standard Chartered
Vision Marine Technologies Stock (NASDAQ: VMAR) Surges on Massive Volume as SEC Filing Details a Potential $8M Share Offering (Dec. 17, 2025)

Vision Marine Technologies Stock (NASDAQ: VMAR) Surges on Massive Volume as SEC Filing Details a Potential $8M Share Offering (Dec. 17, 2025)

Dec. 17, 2025 — Vision Marine Technologies Inc. (NASDAQ: VMAR) is back on traders’ radar after a dramatic spike in price and volume, followed by renewed debate over dilution risk tied to a freshly amended securities filing. The move has been eye-catching even by micro-cap standards: intraday swings, unusually heavy participation, and the kind of “what just happened?” tape action that often appears when momentum collides with financing mechanics. Below is what’s driving Vision Marine Technologies stock today, what the company’s filing actually says, and what investors are watching next. VMAR stock today: explosive volume, sharp swings, and volatility signals
Warner Bros. Discovery (WBD) Stock on Dec. 17, 2025: Board Seen Rejecting Paramount Bid as Netflix Deal Holds, Analysts Reprice the Upside

Warner Bros. Discovery (WBD) Stock on Dec. 17, 2025: Board Seen Rejecting Paramount Bid as Netflix Deal Holds, Analysts Reprice the Upside

Warner Bros. Discovery (NASDAQ: WBD) stock is back in the spotlight on December 17, 2025, as investors weigh a fast-moving takeover drama that now looks less like a two-horse race and more like a regulatory obstacle course with a ticking calendar. WBD shares were recently around $28.90 in trading, with markets reacting to fresh reporting that the company’s board is preparing to recommend shareholders reject Paramount Skydance’s $30-per-share hostile bid and instead stick with the existing deal path with Netflix. Reuters+1 The latest twist: after Paramount’s public, shareholder-directed tender offer tried to force WBD’s hand, one of Paramount’s politically prominent
Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever (ULVR) Today: Stock Price, Latest News and Key Catalysts After the Magnum Spin‑Off (17 December 2025)

Unilever (ULVR) shares closed higher on 17 Dec 2025 as investors track the post‑Magnum strategy, M&A plans, potential UK brand sales, and the Ben & Jerry’s governance dispute. Unilever PLC (LSE: ULVR) ended Wednesday higher in London as the market continues to re-price the consumer-goods giant’s “new look” story: a simplified Unilever following the ice-cream demerger, a sharper focus on Beauty & Wellbeing and Personal Care, and a clearer playbook for bolt‑on acquisitions—while political and governance noise around Ben & Jerry’s shifts to the newly listed Magnum Ice Cream Company. Reuters+3Hargreaves Lansdown+3Reuters+3 Unilever (ULVR) stock price today (17/12/2025): the market

Stock Market Today

Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop